Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · April 17, 2023

Possible Advantage of GLP-1 Receptor Agonists for Kidney Transplant Recipients With Type 2 Diabetes

The Journal of Clinical Endocrinology and Metabolism

 

Additional Info

The Journal of Clinical Endocrinology and Metabolism
Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 Diabetes
J. Clin. Endocrinol. Metab. 2023 Mar 28;[EPub Ahead of Print], T Sato, Y Azuma, C Ozone, M Okazaki, A Takeda, M Okada, K Futamura, T Hiramitsu, N Goto, S Narumi, Y Watarai

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading